ATE540931T1 - Verfahren zur synthese organischer verbindungen - Google Patents

Verfahren zur synthese organischer verbindungen

Info

Publication number
ATE540931T1
ATE540931T1 AT06772447T AT06772447T ATE540931T1 AT E540931 T1 ATE540931 T1 AT E540931T1 AT 06772447 T AT06772447 T AT 06772447T AT 06772447 T AT06772447 T AT 06772447T AT E540931 T1 ATE540931 T1 AT E540931T1
Authority
AT
Austria
Prior art keywords
synthesis
organic compounds
compounds
organic
Prior art date
Application number
AT06772447T
Other languages
German (de)
English (en)
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE540931(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE540931T1 publication Critical patent/ATE540931T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT06772447T 2005-06-09 2006-06-07 Verfahren zur synthese organischer verbindungen ATE540931T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09
PCT/US2006/022154 WO2006135640A2 (en) 2005-06-09 2006-06-07 Process for the synthesis of organic compounds

Publications (1)

Publication Number Publication Date
ATE540931T1 true ATE540931T1 (de) 2012-01-15

Family

ID=37149980

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06772447T ATE540931T1 (de) 2005-06-09 2006-06-07 Verfahren zur synthese organischer verbindungen

Country Status (25)

Country Link
US (2) US7781597B2 (OSRAM)
EP (3) EP1896426B1 (OSRAM)
JP (2) JP5225078B2 (OSRAM)
KR (2) KR101283109B1 (OSRAM)
CN (6) CN102174021B (OSRAM)
AR (1) AR057056A1 (OSRAM)
AT (1) ATE540931T1 (OSRAM)
AU (3) AU2006258050B2 (OSRAM)
BR (1) BRPI0611683A2 (OSRAM)
CA (4) CA2833394C (OSRAM)
DK (2) DK2292607T3 (OSRAM)
ES (3) ES2558696T3 (OSRAM)
GT (1) GT200600202AA (OSRAM)
HU (1) HUE028024T2 (OSRAM)
IN (2) IN2014DN08588A (OSRAM)
JO (1) JO2758B1 (OSRAM)
MX (1) MX2007015609A (OSRAM)
MY (1) MY146795A (OSRAM)
PE (3) PE20100715A1 (OSRAM)
PL (3) PL2292607T3 (OSRAM)
PT (3) PT2292607E (OSRAM)
RU (1) RU2446162C2 (OSRAM)
SI (2) SI2292607T1 (OSRAM)
TW (1) TWI380981B (OSRAM)
WO (1) WO2006135640A2 (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0508140B1 (pt) 2004-03-05 2015-03-17 Nissan Chemical Ind Ltd Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
EP2155701B1 (en) 2007-06-13 2013-12-11 E. I. Du Pont de Nemours and Company Isoxazoline insecticides
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
EP2957284B1 (en) 2007-06-27 2018-01-17 E. I. du Pont de Nemours and Company Animal pest control method
TWI649303B (zh) 2007-08-17 2019-02-01 杜邦股份有限公司 製備４-乙醯基-ｎ-〔２-側氧基-２-〔（２，２，２-三氟乙基）胺基〕乙基〕-１-萘甲醯胺之化合物及方法
AU2008308907B2 (en) 2007-10-03 2014-08-14 Corteva Agriscience Llc Naphthalene isoxazoline compounds for control of invertebrate pests
TWI583664B (zh) * 2008-04-09 2017-05-21 杜邦股份有限公司 羰基化合物及其製備方法
EP2305667A3 (en) 2008-07-17 2011-05-11 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
ES2394258T3 (es) 2008-11-05 2013-01-30 Teva Pharmaceutical Industries Ltd. Formas cristalinas de Nilotinib HCL
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
PH12012502333A1 (en) 2010-05-27 2015-02-04 Corteva Agriscience Llc Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide
US9156852B2 (en) 2011-12-30 2015-10-13 Hanmi Pharm. Co., Ltd Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
US11053220B2 (en) 2018-01-01 2021-07-06 Laurus Labs Ltd Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI770624B (zh) 2018-06-15 2022-07-11 漢達生技醫藥股份有限公司 尼洛替尼十二烷基硫酸鹽在製備用於治療慢性骨髓性白血病之劑型的用途
US11014945B2 (en) * 2019-04-06 2021-05-25 Trinapco, Inc. Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (zh) * 2021-02-23 2024-05-31 四川青木制药有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN116478319B (zh) * 2022-11-07 2025-07-01 华北电力大学 一种离子共价有机聚合物的制备方法及其在碱性环境吸附ReO4-的应用
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法
CN118108670B (zh) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 尼罗替尼中间体3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的精制纯化方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GR851296B (OSRAM) * 1984-05-29 1985-11-25 Pfizer
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
AR037647A1 (es) * 2002-05-29 2004-12-01 Novartis Ag Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) * 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) * 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos

Also Published As

Publication number Publication date
EP2266961B1 (en) 2015-10-21
SI2266961T1 (sl) 2016-02-29
AU2011201044A1 (en) 2011-03-31
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
CN102174019B (zh) 2013-02-13
PL2292607T3 (pl) 2014-09-30
KR20080014010A (ko) 2008-02-13
CA2942046A1 (en) 2006-12-21
IN2014DN08578A (OSRAM) 2015-07-10
PE20100715A1 (es) 2010-10-25
CN102174021A (zh) 2011-09-07
PL1896426T3 (pl) 2012-06-29
PT1896426E (pt) 2012-04-12
JO2758B1 (en) 2014-03-15
JP2008546645A (ja) 2008-12-25
EP2292607A3 (en) 2011-04-27
ES2380489T8 (es) 2012-06-22
MY146795A (en) 2012-09-28
ES2465522T3 (es) 2014-06-06
AR057056A1 (es) 2007-11-14
ES2380489T3 (es) 2012-05-14
CA2886482C (en) 2017-09-05
PE20100716A1 (es) 2010-10-25
KR101249199B1 (ko) 2013-04-03
PT2292607E (pt) 2014-06-24
EP2292607A2 (en) 2011-03-09
ES2558696T3 (es) 2016-02-08
IN2014DN08588A (OSRAM) 2015-07-10
TWI380981B (zh) 2013-01-01
CN101189212A (zh) 2008-05-28
EP1896426B1 (en) 2012-01-11
CN101189212B (zh) 2011-05-18
DK2292607T3 (da) 2014-06-30
JP2013035855A (ja) 2013-02-21
CA2611280C (en) 2014-01-28
CN102174020A (zh) 2011-09-07
SI2292607T1 (sl) 2014-09-30
CA2611280A1 (en) 2006-12-21
JP5225078B2 (ja) 2013-07-03
BRPI0611683A2 (pt) 2010-09-28
CN102174021B (zh) 2013-02-27
US20100280257A1 (en) 2010-11-04
TW200716563A (en) 2007-05-01
CN102180836A (zh) 2011-09-14
CN102180836B (zh) 2012-11-21
AU2006258050B2 (en) 2010-12-09
AU2010241374B2 (en) 2011-11-03
US20080200692A1 (en) 2008-08-21
WO2006135640A2 (en) 2006-12-21
KR20120099028A (ko) 2012-09-06
EP2266961A2 (en) 2010-12-29
PT2266961E (pt) 2016-02-05
CA2833394C (en) 2016-03-29
CA2886482A1 (en) 2006-12-21
EP2266961A3 (en) 2011-07-27
PE20070109A1 (es) 2007-04-02
CN102180796A (zh) 2011-09-14
GT200600202AA (es) 2014-06-09
CN102174019A (zh) 2011-09-07
CA2833394A1 (en) 2006-12-21
HUE028024T2 (en) 2016-11-28
AU2010241374A1 (en) 2010-12-02
PL2266961T3 (pl) 2016-04-29
DK2266961T3 (en) 2016-01-25
US7781597B2 (en) 2010-08-24
MX2007015609A (es) 2008-02-25
CN102174020B (zh) 2012-11-07
KR101283109B1 (ko) 2013-07-05
EP2292607B1 (en) 2014-04-09
EP1896426A2 (en) 2008-03-12
RU2446162C2 (ru) 2012-03-27
RU2007148238A (ru) 2009-07-20
AU2006258050A1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
ATE540931T1 (de) Verfahren zur synthese organischer verbindungen
ATE538111T1 (de) Verfahren zur synthese von 5- alkoxymethylfurfuralethern
ATE459416T1 (de) Verfahren zur beseitigung von endokrin wirksamen verbindungen
ATE515506T1 (de) Verfahren zur synthese von 2- aminothiazolverbindungen als kinaseinhibitoren
ATE474845T1 (de) Verfahren zur synthese von saccharose-6-estern
LT2546225T (lt) Fluorintų organinių junginių gamybos būdas
EP2367905A4 (en) PROCESS FOR PRODUCING CYCLIC ORGANIC COMPOUNDS FROM HARVESTING OILS
ATE434618T1 (de) Spirozyklische verbindungen als hdac-hemmer
ATE400542T1 (de) Verbessertes verfahren zur synthese ungesättigter alkohole
DE502006000036D1 (de) Kontinuierliches Verfahren zur Herstellung SiOC-enthaltender Verbindungen
DE502006001281D1 (de) Verfahren zur herstellung substituierter biphenyle
ATE552250T1 (de) Verfahren zur herstellung von duloxetin und verwandten verbindungen
ATE487709T1 (de) Verfahren zur synthese von 5-(methyl-1h-imidazol- 1-yl)-3-(trifluormethyl)benzolamin
DE112009001327A5 (de) Verfahren zur stereoselektiven Synthese von Phosphor-Verbindungen
DE502006003217D1 (de) Verfahren zur herstellung ungesättigter organosiliciumverbindungen
DE602005012386D1 (de) Verfahren zur Reinigung eines Reaktors
ATE417818T1 (de) Katalytisches eintopfverfahren zur synthese von isocyanaten
DE502005010287D1 (de) Verfahren zur hydrocyanierung
DE602005024305D1 (de) Verfahren zu synthese von glycolonitril
DE60231630D1 (de) Verfahren zur synthese metallorganischer verbindungen
EP1852408A4 (en) METHOD OF SYNTHESIZING UNSATURATED HYDROCARBON
ATE483690T1 (de) Verfahren zur synthese von 5-(methyl-1h-imidazol- 1-yl)-3-(trifluormethyl)-benzeneamin
ZA200709621B (en) Process for the synthesis of organic compounds
DE502006003169D1 (de) Verfahren zur enzymatischen Synthese von Triglyceriden
DE602005021726D1 (de) Verfahren zur Reinigiung organometallischer Verbindungen